Team:Bielefeld-CeBiTec/Notebook/Journal/Biosafety/Jun

From 2014.igem.org

(Difference between revisions)
Line 136: Line 136:
<ul>
<ul>
<li>Annealing temperature: 55 °C</li>
<li>Annealing temperature: 55 °C</li>
 +
                <li>Primer: <a href="http://parts.igem.org/Part:BBa_K1465403" target="_blank">BBa_K1465403</a> and <a href="http://parts.igem.org/Part:BBa_K1465404" target="_blank">BBa_K1465404</a></li>
<li>Bands as expected (3004 bp)</li>
<li>Bands as expected (3004 bp)</li>
</ul>
</ul>

Revision as of 02:32, 9 October 2014


June

  • Design of the Primer for the integration of the konstitutive alanine racemase alr into the pSB1C3-Backbone.
  • Successful amplifikation of the oligonucleotide containing the flanking sites for the deletion of alr and purification using the gel extraction clean-up kit from Promega.
  • Transformation of the oligonucleotide containing the flanking sites for the deletion of alr. The successful replacement of the constitutive alanine racemase was verified via kanamycin selection and Colony PCR (alr_Ec_control1, alr_Ec_control2)
  • Resulting in the genotype KRX kan:alr, DH5aplha kan:alr repsectivly.
  • The successfull deletion of the chromosomal kanamycin resistance was established by the plasmid Flp705 as described in the Genebridge RedET-System protocol.
    The plasmid is removed by a temperature shift and the removal of the kanamycin resistance is verified by streaking colonies in parallel on LB-kanamycin and LB agar.
  • Resulting in the genotype KRX ∆ alr, DH5aplha ∆ alr repsectivly.